JUPITER NEUROSCIENCES, INC. cotiza a 3.36 USD y tiene una capitalización bursátil de $4M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supple…
| Periodo | 2025-11 | 2025-08 | 2025-05 | 2025-03 |
|---|---|---|---|---|
| Real | $-5.25 | $-5.25 | $-3.75 | $-3.75 |
| Estimado | $-6.00 | $-5.25 | $-2.25 | $-1.50 |
| Sorpresa | +12.5% | +0.0% | -66.7% | -150.0% |
| Métrica | JUNS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 80.6% | 57.0% | +23.6% |
| Operating Margin | -40873.2% | -38.6% | -40834.6% |
| Net Margin | -39662.8% | -33.6% | -39629.2% |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -155.4% | -32.0% | -123.4% |
| Current Ratio | 0.65 | 2.84 | -2.19 |
| Debt / Equity | — | 0.28 | — |